(CPB) Campbell’s - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1344291091

Soups, Sauces, Juices, Snacks, Beverages, Pasta

CPB EPS (Earnings per Share)

EPS (Earnings per Share) of CPB over the last years for every Quarter: "2020-10": 1.02, "2021-01": 0.84, "2021-04": 0.57, "2021-07": 0.55, "2021-10": 0.89, "2022-01": 0.69, "2022-04": 0.7, "2022-07": 0.56, "2022-10": 1.02, "2023-01": 0.8, "2023-04": 0.68, "2023-07": 0.5, "2023-10": 0.91, "2024-01": 0.8, "2024-04": 0.75, "2024-07": 0.63, "2024-10": 0.89, "2025-01": 0.74, "2025-04": 0.73, "2025-07": 0.62,

CPB Revenue

Revenue of CPB over the last years for every Quarter: 2020-10: 2340, 2021-01: 2279, 2021-04: 1984, 2021-07: 1873, 2021-10: 2236, 2022-01: 2209, 2022-04: 2130, 2022-07: 1987, 2022-10: 2575, 2023-01: 2485, 2023-04: 2229, 2023-07: 2068, 2023-10: 2518, 2024-01: 2456, 2024-04: 2369, 2024-07: 2293, 2024-10: 2772, 2025-01: 2685, 2025-04: 2475, 2025-07: 2321,

Description: CPB Campbell’s

The Campbells Company is a leading manufacturer and marketer of food and beverage products, operating through two main segments: Meals & Beverages and Snacks. The Meals & Beverages segment offers a diverse portfolio of brands, including Campbells, Swanson, Prego, Pace, and Raos, across various categories such as soups, sauces, and juices. The Snacks segment features brands like Pepperidge Farm, Snyders of Hanover, Lance, and Kettle Brand, offering a range of snacking products.

From a business perspective, Campbells has a strong presence in the US and Canada, with a growing footprint in Latin America. The companys products are sold through various channels, including retail food chains, mass discounters, e-commerce, and convenience stores. With a history dating back to 1869, Campbells has established itself as a trusted brand, leveraging its scale and distribution network to drive growth.

To further analyze Campbells performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin can be examined. For instance, Campbells has been focusing on portfolio optimization, divesting non-core brands and investing in marketing and innovation to drive growth. Additionally, metrics like return on equity (RoE) of 11.78% and a forward P/E ratio of 10.74 suggest a relatively stable and profitable business. Other relevant KPIs could include sales growth, market share, and dividend yield, which can provide insights into the companys ability to generate returns for shareholders.

From a valuation perspective, Campbells common stock (CPB) can be evaluated using metrics like price-to-sales (P/S) ratio, enterprise value-to-EBITDA (EV/EBITDA) ratio, and dividend yield. These metrics can help determine whether the stock is fairly valued, undervalued, or overvalued relative to its peers and the broader market. By analyzing these KPIs, investors can gain a more comprehensive understanding of Campbells financial health, competitive position, and growth prospects.

CPB Stock Overview

Market Cap in USD 8,976m
Sub-Industry Packaged Foods & Meats
IPO / Inception 1985-07-01

CPB Stock Ratings

Growth Rating -61.5%
Fundamental 56.6%
Dividend Rating 50.2%
Return 12m vs S&P 500 -40.8%
Analyst Rating 3.13 of 5

CPB Dividends

Dividend Yield 12m 5.06%
Yield on Cost 5y 3.81%
Annual Growth 5y 1.40%
Payout Consistency 72.3%
Payout Ratio 52.4%

CPB Growth Ratios

Growth Correlation 3m -33.7%
Growth Correlation 12m -91.8%
Growth Correlation 5y -14%
CAGR 5y -12.01%
CAGR/Max DD 3y (Calmar Ratio) -0.28
CAGR/Mean DD 3y (Pain Ratio) -0.60
Sharpe Ratio 12m -1.29
Alpha -37.80
Beta 0.023
Volatility 22.66%
Current Volume 4297.9k
Average Volume 20d 5263.6k
Stop Loss 29.8 (-3.4%)
Signal -0.24

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (602.0m TTM) > 0 and > 6% of Revenue (6% = 615.2m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -6.57% (prev -14.38%; Δ 7.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 1.14b > Net Income 602.0m (YES >=105%, WARN >=100%)
Net Debt (7.08b) to EBITDA (1.56b) ratio: 4.54 <= 3.0 (WARN <= 3.5)
Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (299.0m) change vs 12m ago 0.34% (target <= -2.0% for YES)
Gross Margin 30.42% (prev 30.83%; Δ -0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 68.06% (prev 63.25%; Δ 4.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 3.26 (EBITDA TTM 1.56b / Interest Expense TTM 345.0m) >= 6 (WARN >= 3)

Altman Z'' 1.68

(A) -0.05 = (Total Current Assets 2.23b - Total Current Liabilities 2.91b) / Total Assets 14.90b
(B) 0.32 = Retained Earnings (Balance) 4.69b / Total Assets 14.90b
(C) 0.07 = EBIT TTM 1.12b / Avg Total Assets 15.07b
(D) 0.43 = Book Value of Equity 4.69b / Total Liabilities 10.99b
Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 56.59

1. Piotroski 2.50pt = -2.50
2. FCF Yield 4.47% = 2.23
3. FCF Margin 6.99% = 1.75
4. Debt/Equity 1.85 = 1.00
5. Debt/Ebitda 4.54 = -2.50
6. ROIC - WACC (= 4.11)% = 5.14
7. RoE 15.51% = 1.29
8. Rev. Trend 19.76% = 1.48
9. EPS Trend -26.07% = -1.30

What is the price of CPB shares?

As of October 20, 2025, the stock is trading at USD 30.86 with a total of 4,297,916 shares traded.
Over the past week, the price has changed by +3.56%, over one month by -6.55%, over three months by +1.46% and over the past year by -31.77%.

Is Campbell’s a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Campbell’s is currently (October 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 56.59 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CPB is around 28.30 USD . This means that CPB is currently overvalued and has a potential downside of -8.3%.

Is CPB a buy, sell or hold?

Campbell’s has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold CPB.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 12
  • Sell: 3
  • Strong Sell: 2

What are the forecasts/targets for the CPB price?

Issuer Target Up/Down from current
Wallstreet Target Price 34.6 12.1%
Analysts Target Price 34.6 12.1%
ValueRay Target Price 30.2 -2%

Last update: 2025-10-17 02:29

CPB Fundamental Data Overview

Market Cap USD = 8.98b (8.98b USD * 1.0 USD.USD)
P/E Trailing = 15.0
P/E Forward = 12.7389
P/S = 0.8754
P/B = 2.4133
P/EG = 0.6736
Beta = 0.023
Revenue TTM = 10.25b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.56b USD
Long Term Debt = 6.06b USD (from longTermDebt, last quarter)
Short Term Debt = 858.0m USD (from shortTermDebt, last quarter)
Debt = 7.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.08b USD (from netDebt column, last quarter)
Enterprise Value = 16.06b USD (8.98b + Debt 7.21b - CCE 132.0m)
Interest Coverage Ratio = 3.26 (Ebit TTM 1.12b / Interest Expense TTM 345.0m)
FCF Yield = 4.47% (FCF TTM 717.0m / Enterprise Value 16.06b)
FCF Margin = 6.99% (FCF TTM 717.0m / Revenue TTM 10.25b)
Net Margin = 5.87% (Net Income TTM 602.0m / Revenue TTM 10.25b)
Gross Margin = 30.42% ((Revenue TTM 10.25b - Cost of Revenue TTM 7.13b) / Revenue TTM)
Gross Margin QoQ = 30.37% (prev 29.41%)
Tobins Q-Ratio = 1.08 (Enterprise Value 16.06b / Total Assets 14.90b)
Interest Expense / Debt = 1.18% (Interest Expense 85.0m / Debt 7.21b)
Taxrate = 21.20% (39.0m / 184.0m)
NOPAT = 885.8m (EBIT 1.12b * (1 - 21.20%))
Current Ratio = 0.77 (Total Current Assets 2.23b / Total Current Liabilities 2.91b)
Debt / Equity = 1.85 (Debt 7.21b / totalStockholderEquity, last quarter 3.90b)
Debt / EBITDA = 4.54 (Net Debt 7.08b / EBITDA 1.56b)
Debt / FCF = 9.87 (Net Debt 7.08b / FCF TTM 717.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 602.0m / Total Assets 14.90b)
RoE = 15.51% (Net Income TTM 602.0m / Total Stockholder Equity 3.88b)
RoCE = 11.31% (EBIT 1.12b / Capital Employed (Equity 3.88b + L.T.Debt 6.06b))
RoIC = 7.91% (NOPAT 885.8m / Invested Capital 11.20b)
WACC = 3.80% (E(8.98b)/V(16.19b) * Re(6.10%) + D(7.21b)/V(16.19b) * Rd(1.18%) * (1-Tc(0.21)))
Discount Rate = 6.10% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.66% ; FCFE base≈697.4m ; Y1≈668.9m ; Y5≈652.8m
Fair Price DCF = 39.11 (DCF Value 11.64b / Shares Outstanding 297.7m; 5y FCF grow -5.44% → 3.0% )
EPS Correlation: -26.07 | EPS CAGR: -16.56% | SUE: 2.22 | # QB: 2
Revenue Correlation: 19.76 | Revenue CAGR: -3.71% | SUE: -0.56 | # QB: 0

Additional Sources for CPB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle